Uncontrolled blood pressure (BP) is linked to increased risk of obstructive sleep apnea (OSA). However, few studies have assessed the impact of this relationship among blacks with metabolic syndrome. Data for this study were collected from 1,035 blacks (mean age = 62±13 years) enrolled in the Metabolic Syndrome Outcome (MetSO) study. Patients with a score ≥6 on the Apnea Risk Evaluation System (ARES™) were considered at risk for OSA. Of the sample, 77.1% were low-to-high OSA risk and 92.3% were hypertensive, of which 16.8% had uncontrolled BP levels. Analysis also showed 60.4% were diabetic, 8.9% had a stroke history, 74.3% had dyslipidemia, 69.8% were obese and 30.9% had a history of heart disease. Logistic regression analyses were employed to investigate associations between uncontrolled BP and OSA risk, while adjusting for known covariates. Findings showed that uncontrolled BP independently increased the odds of OSA risk twofold (OR = 2.02, 95% CI = 1.18-3.48, p < 0.05). Our findings show that uncontrolled BP was associated with a twofold greater risk of OSA among blacks, suggesting that those with metabolic syndrome and who have uncontrolled BP should be screened for the presence of OSA.
INTRODUCTION
According to the American Heart Association, 34% of US adults meet criteria for metabolic syndrome (MetS), an insulin-resistant condition that increases the risk of cardiovascular Users may view, print, copy, and download text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use:http://www.nature.com/authors/editorial_policies/license.html#terms disease (CVD), stroke and diabetes (T2DM). 1 Findings from the National Health and Nutrition Examination Survey indicate that blacks have a lower prevalence of MetS compared to whites. 2 , 3 These findings are inconsistent with evidence that blacks are at increased risk for three of the five MetS components including, waist circumference >102 cm in men and >88 cm in women; blood pressure (BP) level ≥130/≥85 mmHg; and high fasting plasma glucose ≥100 mg/dL. 4 , 5 Risk for dyslipidemia among blacks tend to be lower relative to whites. Moreover, these findings are inconsistent with overwhelming evidence that indicates that blacks are at increased risk for obstructive sleep apnea (OSA) and cardiovascular disease, 6 commonly observed among individuals with metabolic syndrome. 7 Such findings should be interpreted cautiously, as they may lead to the misconception that blacks are at reduced risk for Barcelo et al. 13 observed a decrease in insulin resistance after three months of continuous positive airway pressure only in patients who reported excessive daytime sleepiness but not for patients who reported no daytime sleepiness. Consequently, these limitations point to other possible causes of the MetS-OSA association. Of the two remaining MetS components (dyslipidemia and hypertension), hypertension appears to offer a higher possibility of explaining the MetS-OSA relationship. Recent evidence on the negative effects of resistant hypertension on OSA provide a new framework for understanding the role hypertension plays in the development and maintenance of OSA. 7 However, little is known about: a) how abnormal BP levels impacts OSA risk; and b) how this association manifests in diverse populations such as blacks who are at greater risk for uncontrolled BP and hypertension. 14 This study ascertained the independent associations of uncontrolled BP with the risk of OSA. It also assessed whether dyslipidemia, diabetes, and obesity have significant covarying effects on hypothesized associations between uncontrolled BP and risk of OSA.
MATERIALS AND METHODS

Study Population
Data for the present study were collected from 1,035 blacks (mean age = 62±13 years) enrolled in the Metabolic Syndrome Outcome (MetSO) study, a cohort study of patients with metabolic syndrome. All participants were recruited from four primary-care clinics in Brooklyn, NY. During initial interviews, patients provided sociodemographic variables, health risk factors, and history of comorbid diseases, which were verified using an electronic medical record system (Allscripts). The study was approved by the SUNY Downstate Medical Center research ethics board and informed consents were obtained from all participants.
Measures and Procedures
Patients who fit the study's inclusion criteria were recruited by study staff from participating primary-care settings. Participants who identified as Black, African-American or of African ancestry, 18 years and older, who fit metabolic syndrome diagnosis were targeted. Also, patients who are pregnant or breastfeeding, involved in another study, unable to provide consent, and those who recently had a heart attack within the past 122 weeks were all excluded. Those who agreed to participate provided an informed consent before enrollment. This was followed by administration of a brief questionnaire on sleep problems, medical history, and use of medications. They also provided responses to the Apnea Risk Evaluation System (ARES™) Questionnaire, which has superior reliability in diverse groups, as compared to other apnea risk instruments. 15 Patients with a score ≥ 6 on the Apnea Risk Evaluation System (ARES™) were considered at risk for OSA. 16 The ARES questionnaire gathers information on: a) demographic and anthropometric information; b) diseases associated with risk for sleep apnea (hypertension, diabetes, heart disease, or stroke), and c) prior diagnosis of sleep apnea, the Epworth Sleepiness Scale, and frequency rating for snoring, waking up choking, and having been told that patients stopped breathing during sleep. The psychometric properties of ARES are robust with sensitivity of 0.94, moderate specificity of 0.79, positive predictive value of 0.91, and negative predictive value of 0.86. 16 Information on body mass index (BMI), BP, high-density lipoprotein cholesterol (HDL-), low-density lipoprotein cholesterol (LDL), and fasting plasma glucose (FPG) or hemoglobin (HbA1c) for diabetic patients were obtained from electronic medical records. BMI was used instead of waist circumference because preliminary analyses indicate similar findings for BMI and waist circumference. Additionally ROC (area under the curve) analysis confirmed that both BMI and waist circumference had similar sensitivity and specificity in predicting OSA risk. Following the guidelines set by the Seventh Joint National Committee on High Blood Pressure (JNC 7), uncontrolled BP was defined as average systolic and diastolic BP ≥140/90 mmHg (for those without comorbidity), or average clinic SBP ≥130 mmHg or DBP ≥ 80 mmHg (for those with diabetes or kidney disease). 14 , 17 -19 BP was measured three times on two different visits at an office setting and averaged for a single BP, which was used to derive whether the participant had uncontrolled BP or not.
Statistical Analysis
To test the hypothesis that patients with uncontrolled BP were more likely to be at high OSA risk, compared with those with whose BP is we utilized multivariate-adjusted logistic regression modeling. Covariates entered in the model were age, sex, obese (defined as BMI ≥ 30 Kg/m 2 ), a history of diabetes, dyslipidemia, heart disease, and depression. Before constructing the model, correlational analyses were performed to assess associations 
RESULTS
Sixty-nine percent (69%) were female, 42.9% had an annual income lower than $10K (significantly lower than the median family income in the United States). 20 Table 4 ).
DISCUSSION
Our findings indicate that patients with uncontrolled BP are at greater OSA risk, independent of other well-established MetS risk factors like obesity (elevated BMI), Type II diabetes and triglyceride levels. Our investigation of the potential impact uncontrolled BP has on OSA among blacks is novel because previous studies primarily focused on how OSA causes hypertension. And studies that investigated the influence BP has on OSA primarily focus on resistant hypertension, a less prevalent hypertension phenotype and a condition largely defined by patients' level of responsiveness to antihypertensive medications. Identifying uncontrolled BP as a predictor of OSA, which is the main purpose of our paper, provides a unique and more economical opportunity to treat OSA, in a metabolic syndrome (MetS) population, through proper and more effective BP management.
Though our study is not the first to investigate the prevalence of MetS among blacks and the shared risk between OSA and MetS through a hypertension lens; 21 to our knowledge, it is the first to investigate the association between uncontrolled BP and OSA, using a black sample. Our approach is informed by compelling evidence that OSA is one of the strongest predictors of cardiometabolic risk and plays a central role in the pathophysiological relationship between metabolic syndrome and cardiovascular disease and diabetes. 9 These studies have shown that approximately 60% of individuals with metabolic syndrome have moderate to severe OSA. 22 There is even stronger evidence that OSA impacts some of the five metabolic syndrome components. 2 , 13 Hypertension, specifically uncontrolled blood pressure (SBP≥140 mm Hg and DBP ≥90 mmHg), is strongly associated with OSA despite aggressive antihypertensive medication regimen. 14 , 23 OSA is highly prevalent among patients with uncontrolled blood pressure levels 25 , 26 and treatment of OSA through continuous positive airway pressure reduces daytime and nocturnal blood pressure. 26 , 27 Of the five MetS components, obesity and diabetes have been considered the most likely causes for the MetS-OSA association. 28 Obesity is considered the most established risk factor, as several studies have found that body mass index (BMI), neck circumference 28 and visceral fat 29 increase an individual's risk of OSA. Most of these studies indicate physiological (mechanical), inflammatory and hormonal explanations for the effect obesity have on OSA. Genomic research shows that shared and non-shared biological factors, such as percentage of body fat, serum/leptin levels, waist: hip ratio and lipid metabolism, are linked to apnea/hypopnea index --a marker of OSA risk--and BMI among whites 11 but not among blacks because they have lower rates of abdominal fat than their white counterparts. Inflammatory mechanisms are suggested by a strong association between OSA, obesity and inflammatory biomarkers. Specifically, OSA is associated with aberrant lipid and glycemic homeostasis and systemic inflammation in both non-obese and obese individuals. Physiological research suggests that obesity increases hypoventilation, 30 which can cause a cascade of events such as pharyngeal collapse, decreased lung volume and the production of adipokines (signaling proteins in the central nervous system), which restricts normal breathing pattern while sleeping 31 and eventually leads to apneic events.
Despite convincing evidence that obesity is the primary predictor of OSA risk, 21 recent studies show that surgical 32 and dietary 33 weight loss did not reduce the amount of AHI, which opens the possibility of a more robust OSA predictor. The current findings make a compelling case that uncontrolled blood pressure is a robust OSA risk factor and clinical correlate. Uncontrolled BP was the strongest predictor of OSA compared with other MetS indicators and the use of antihypertensive medication. Therefore, it could be inferred that individuals who engage in blood-pressure-lowering activities reduce their risk for OSA; as well as treating OSA could reduce BP to normotensive ranges. 34 Perhaps secondary level treatment of OSA through blood pressure education, monitoring, and management might yield greater clinical outcomes as compared to primary OSA treatments, such as surgery and continuous positive airway pressure treatment. 35 -39 Blood pressure treatment has a higher adherence rate and lower non-adherence rate (BP: 28% vs CPAP: 28-83%) 40 -42 and is often considered more economical than treatment with continuous positive airway pressure. 41 , 42 There are several limitations that should be considered in interpreting our results. First, since our sample only included blacks, our findings cannot be generalized to other racial and ethnic groups. Second, the study does not offer a causal mechanism for the relationship between uncontrolled BP and OSA. Despite these limitations, the current findings provide initial evidence needed to establish how uncontrolled BP might contribute to increased OSA risk.
CONCLUSION
In conclusion, our study shows that uncontrolled BP is independently associated with OSA in a sample of black patients with MetS. Specifically, these data demonstrate that blacks with uncontrolled BP are two times more likely to be at risk for OSA, as compared to those with controlled BP. Additionally, it appears that blacks with uncontrolled BP appear to be more at risk for OSA than those who are obese, have diabetes or glucose resistance problems, or dyslipidemia. Our findings provide initial evidence for addition of uncontrolled BP as a risk factor for screening of OSA risk. Such addition should improve diagnostic screening for OSA and may have potential significance for making treatment decision, such that individuals with metabolic syndrome and uncontrolled BP will be screened for OSA. 
